This inventor holds 1 USPTO granted patent. Top assignee: Arkion Life Sciences, LLC. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Steven C. Ross: Innovator in Cytokine Inhibition
Introduction
Steven C. Ross is an accomplished inventor based in Wilmington, DE (US). He has made significant contributions to the field of immunology through his innovative work on cytokine inhibitory factors. His research focuses on developing methods to modulate the immune system, which has important implications for treating various inflammatory conditions.
Latest Patents
Steven C. Ross holds a patent for a composition comprising a substantially purified Cytokine Inhibitory Factor (CIF). This composition is characterized by its ability to inhibit RNA transcription of pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-α), interleukin-1-beta (IL-1β), and interleukin-2 (IL-2). The patent also outlines methods for purifying the Cytokine Inhibitory Factor and for modulating the immune system of an animal using this composition. He has 1 patent to his name.
Career Highlights
Steven is currently associated with Arkion Life Sciences, LLC, where he continues to advance his research in cytokine inhibition. His work has the potential to lead to new therapeutic strategies for managing immune responses in various diseases.
Collaborations
Some of his notable coworkers include Subramanian Iyer and Ruye Xing, who have collaborated with him on various projects related to cytokine research.
Conclusion
Steven C. Ross is a key figure in the field of immunology, with a focus on cytokine inhibition. His innovative work and patent contributions are paving the way for advancements in immune system modulation.